Cite

HARVARD Citation

    McDermott, J. et al. (2022). The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack. Expert review of clinical pharmacology. 15 (7), pp. 811-825. [Online]. 
  
Back to record